marketnews

Florida Legislature Approves Sanctions Against Iran in Support of Israel

The Florida Legislature Takes Strong Stance on Foreign Policy Expanding Sanctions and Support for Israel TALLAHASSEE, Fla. — The Florida Legislature wrapped up a special session Wednesday, bolstering Gov. Ron DeSantis’ foreign policy resume by expanding sanctions against companies that do business with Iran in advance of Wednesday night’s GOP presidential debate in Miami. The…

Read More

Important Deadline Approaching for DCGO Investors: Protect Your Rights with Experienced Counsel, Advises Rosen Recognized Investor Counsel

Important Deadline Approaching for DCGO Investors Important Deadline Approaching for DCGO Investors: Protect Your Rights with Experienced Counsel, Advises Rosen Recognized Investor Counsel Description: NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DocGo Inc. (NASDAQ: DCGO) between November 8, 2022…

Read More

Breaking Barriers: How Research Institutions are Embracing and Implementing New Innovations

Cayuse Continues to Expand its Reach in Electronic Research Administration Portland, Oregon, Nov. 08, 2023 (GLOBE NEWSWIRE) — Cayuse, the leader in electronic research administration (eRA) software, today announced additional successful implementations of Cayuse eRA solutions among several notable research institutions. Following another successful Connect by Cayuse virtual conference this fall, Cayuse leadership is proud…

Read More

Amber Group Joins Forces with Solidus Labs to Strengthen Integrity in the Crypto Market: A Game-Changing Partnership

Solidus Labs Partners with Amber Group to Enhance Crypto Trade Surveillance Introduction Solidus’ HALO platform, the leading crypto trade surveillance and market integrity hub, will enhance Amber Group’s capabilities in risk monitoring, market abuse prevention, and compliance with evolving regulatory requirements. Solidus Labs, the category-definer for crypto-native integrity solutions, announced today that it has partnered…

Read More

Unveiling Success: CytomX Therapeutics’ Third Quarter 2023 Financial Results and Exciting Business Update

CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update Exciting Developments in the Pipeline During the third quarter of 2023, CytomX Therapeutics made significant progress in advancing their innovative pipeline of therapies. Anticipation is high for the initial Phase 1 dose escalation data of CX-904 (EGFRxCD3 T-cell engager) expected in the first…

Read More